-
Signature
-
/s/ Vanina de Verneuil, Attorney-In-Fact
-
Issuer symbol
-
VIR
-
Transactions as of
-
30 May 2025
-
Net transactions value
-
-$16,149
-
Form type
-
4
-
Filing time
-
02 Jun 2025, 19:26:09 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Napolitano Janet |
Director |
C/O VIR BIOTECHNOLOGY, INC., 1800 OWENS STREET, SUITE 900, SAN FRANCISCO |
/s/ Vanina de Verneuil, Attorney-In-Fact |
02 Jun 2025 |
0001821008 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
VIR |
Common Stock |
Award |
$0 |
+8,000 |
+69% |
$0.000000 |
19,616 |
30 May 2025 |
Direct |
F1, F2 |
| transaction |
VIR |
Common Stock |
Sale |
$16,149 |
-3,200 |
-16% |
$5.05 |
16,416 |
02 Jun 2025 |
Direct |
F3, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
VIR |
Stock Option (Right to Buy) |
Award |
$0 |
+16,000 |
|
$0.000000 |
16,000 |
30 May 2025 |
Common Stock |
16,000 |
$4.94 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: